TrialMolecular oncology2022

Immune microenvironment in patients with mismatch-repair-proficient oligometastatic colorectal cancer exposed to chemotherapy: the randomized MIROX GERCOR cohort study.

Marine Jary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.